Compare stocks

Getinge AB is a Swedish company that specializes in providing products and solutions for healthcare and life sciences. The company’s core business includes the development and manufacturing of equipment and systems for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life science operations. Founded in 1904, Getinge is headquartered in Gothenburg, Sweden, and operates globally with a presence in numerous countries. The company's strategic positioning is strengthened by its focus on innovation and comprehensive solutions that address the complex challenges of medical and pharmaceutical processes, aiming to enhance patient outcomes and operational efficiency.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.